U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804524) titled 'Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH' on Aug. 17.
Brief Summary: To study the effect of relocation from high altitude (Quito Ecuador: 2850m) to sea level on pulmonary resistance (sPAP/CO) and other hemodynamic outcomes in patients with pulmonary arterial hypertension PAH, who live permanently >2600m.
Study Start Date: Sept. 25
Study Type: INTERVENTIONAL
Condition:
Pulmonary Arterial Hypertension (PAH)
Pulmonary Vascular Disease
High Altitude
Echocardiography
Pulmonary Resistance
Hemodynamic Changes
Intervention:
BEHAVIORA...